Scott Dreyer, EVP & Chief Commercial Officer at COLLEGIUM PHARMACEUTICAL, INC (COLL), sold 35,200 shares at $47.89 ($1.7M) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($1.7M) by EVP & Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.89 | 11,125 | $533K | 31.4% |
| 2 | $47.89 | 11,125 | $533K | 31.4% |
| 3 | $48.66 | 6,475 | $315K | 18.6% |
| 4 | $48.66 | 6,475 | $315K | 18.6% |
| Total | $48.17 avg | 35,200 | $1.7M | 100% |
| Filing → |
| COLL | SELL | 2025-08-15 | $370K | — | Filing → |
| COLL | SELL | 2025-03-24 | $1.2M | — | Filing → |
| COLL | SELL | 2025-03-18 | $462K | — | Filing → |